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Treatment of homogeneous dopamine /I-hydroxylase (DBH) preparations from bovine adrenals with the inhibitor 
phenylhydrazine (PH) changed the structureless absorption spectrum of DBH into spectra with a maximum at 350 nm. 
A product with this absorption spectrum could be detached with pronase, enabling its isolation. It appeared to be the 
C(5) hydrazone of pyrroloquinoline quinone (PQQ) and PH. as judged from its properties and the fact that it could be 
transformed into PQQ itself. From the yield obtained a ratio of 0.85 PQQ per enzyme subunit was calculated. In contrast 
to copper-quinoprotein amine oxidases (EC I .4.3.6), hydrazone formation in DBH did not require saturation of the mix- 
ture with 0,. DBH is the first copper-quinoprotein hydroxylase found so far. The implications of this finding for the 
current views on mechanism of action and inhibition by hydrazines are discussed. The success of the recently developed 
‘hydrazine method’ [(1987) FEBS Lett. 221, 299-3041 for all different types of amine oxidoreductases, suggest that the 
method could also be applied to other enzymes for which hydrazines are inhibitors and where the identity of the cofactors 
has not been established or the presence of PQQ is suspected. 
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1. INTRODUCTION 
Dopamine ,9-hydroxylase (DBH, EC 1.14.17.1) 
has been classified as a copper-protein monoox- 
ygenase which catalyzes the hydroxylation of 
dopamine to noradrenaline: 
dopamine + 02 + 2[H] --+ noradrenaline + H20 
The kinetics of this enzyme have been intensively 
studied, leading to a scheme for the catalytic cycle 
in which the copper ions form part of the hydrox- 
ylating center [l]. However, the proposed 
mechanism is mainly based on this approach and 
the intermediates of the enzyme in the catalytic cy- 
cle have not been studied so well. For instance, the 
assumed reduction of Cu(I1) to Cu(1) ions by 
ascorbic acid has been detected by ESR- 
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spectroscopy but is not documented by changes in 
the absorption spectrum of the enzyme. Perhaps 
this one-sidedness has led to the general notion 
that the enzyme is a colorless protein (although the 
complete UV/VIS absorption spectrum has never 
been published) with copper ions as the only 
cofactor. 
A similar situation exists with respect to the 
mechanism of inhibition of DBH: a lot of informa- 
tion has been obtained on the inhibitor specificity 
[2] but product analysis of the inhibited enzyme 
has scarcely been performed. For instance, the ef- 
fect with hydrazines (irreversible inhibitors for 
DBH) has been ascribed to enzymic decomposition 
of these compounds, leading to the formation of a 
carbon-centered radical attacking the active site 
[2]. However, the putative product in the enzyme 
has not been characterized so that much uncertain- 
ty remains with respect to the proposed 
mechanism. In addition, although it is known that 
this type of inhibitor induces large spectral changes 
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in inhibition-sensitive enzymes, this has not been 
documented for DBH. 
During the past few years, a method has been 
developed to elucidate the nature of the covalently- 
bound organic cofactor in copper-containing 
amine oxidases (EC 1.4.3.6). The method is based 
on enzyme derivatization with suitable hydrazine 
inhibitors under specified conditions, detaching 
the product formed with protease, purifying the 
colored adduct, and comparing it with the cor- 
responding model compound. Using this 
‘hydrazine method’ the identity (and quantity) of 
the cofactor could be unambiguously established 
to be pyrroloquinoline quinone (PQQ) in several 
mammalian and microbial copper-containing 
amine oxidases [3-61, as well as in microbial 
methylamine dehydrogenase (EC 1.4.99.3) [7]. 
Since many other metal-containing ‘enzymes 
have never been investigated for the presence of an 
organic cofactor (although participation of such a 
compound could explain anomalies in the pro- 
posed mechanisms in several cases) it could be 
reasoned that the presence of PQQ (at least 3 sites 
available for metal-ion binding) has been over- 
looked in these enzymes so that application of the 
hydrazine method should be tried. For these 
reasons and a possible relatedness to the copper- 
quinoprotein amine oxidases, DBH seemed an at- 
tractive candidate to test the suitability of the 
hydrazine method and to probe the versatility of 
PQQ as a cofactor. 
2. MATERIALS AND METHODS 
2.1. Purification of DBH 
Since commercial DBH preparations appeared to be in- 
homogeneous, the following purification step was performed. 
50 mg of lyophilized enzyme (Sigma) was dissolved in 2 ml of 
0.1 M sodium phosphate, pH 7.0. The solution was injected (in 
portions) on an FPLC gel filtration column (Pharmacia 
Superose 12 HR 10/30) in 0.1 M sodium phosphate, pH 7.0, 
using a flow rate of 0.5 ml/min. The eluate was monitored with 
absorbance detection (Hewlett-Packard 104OA photodiode ar- 
ray detector) at 280 nm. Active fractions were pooled, and 
stored at - 70°C. 
Preparation of the copper-free enzyme was achieved as 
described 181. 
2.2. Adduct formation and characterization 
Derivatization of the cofactor in DBH with PH and isolation 
of the adduct was performed as described [7], with the follow- 
ing modifications: to a solution (2.5 ml) of DBH (4 mg) in 
0.1 M sodium phosphate, pH 7.0, 2 pl of a 0.1 M solution of 
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phenylhydrazine (PH) in cont. HsPOb/ethanol (1: 1, v/v) [9] 
was added; the mixture was incubated at 40°C for 16 h; pro- 
teolysis was performed by addition of 2 mg of pronase E 
(Boehringer, Mannheim) and incubation at 40°C for 6 h. 
HPLC (on a 4,um C18 RCM cartridge) of the adduct, its 
transformation into PQQ by dissolving in MezSO, the prepara- 
tion of the model hydrazone from PQQ and PH, and the deter- 
mination of PQQ concentrations were all performed as 
described [7]. 
2.3. Enzyme assay 
A spectrophotometric assay, based on the tyramine- 
dependent oxidation of ferrocyanide to ferricyanide [lo], was 
used to determine the enzymic activity of DBH under at- 
mospheric conditions. Initial rates were derived from the in- 
crease in absorbance at 420 nm at 25°C. Reaction mixtures 
contained 10 mM 2-(N-morpholino)ethane sulfonic acid, 0.2 M 
sodium acetate, pH 6.0, 30 mM N-ethylmaleimide, 10 mM 
tyramine, and 1 mM GFe(CN)G. Activities were calculated us- 
ing a molar extinction coefficient for &Fe(CN)6 of 
1000 M-‘.cm-’ [lo]. The amount of purified DBH was 
calculated using the specific absorption coefficient determined 
by Skotland and Ljones (111 (A:;::’ = 1.24). 
2.4. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis in the absence and 
presence of SDS was performed on the Pharmacia Phastsystem 
equipment according to the instructions given by the manufac- 
turer (Phastsystem separation technique file nos 120 and 110, 
respectively). Protein staining occurred with Phastgel Blue R 
(according to Phastsystem Development technique file no.200), 
while enzyme activity staining was carried out according to 
Ljones et al. [12]. 
3. RESULTS 
Starting with a commercially available prepara- 
tion, a single purification step was sufficient to 
provide an enzyme preparation with a specific ac- 
tivity of 5.4 pmol [Fe(CN)s14- oxidized emin-’ . 
mg-‘, comparable with the value (4.8 kmol 
[Fe(CN),s]4- oxidized ’ min-’ . mg-‘) ascribed to a 
homogeneous DBH preparation by others [ 121. 
The preparation appeared indeed to be homoge- 
neous, as revealed by polyacrylamide gel electro- 
phoresis in the absence and presence of SDS since 
no other bands were detectable. Therefore, this 
preparation was suited to investigate the presence 
of an organic cofactor. 
As shown in fig. 1, DBH is not a ‘colorless pro- 
tein’ since substantial absorbance is observed 
above 300 nm, resulting in an, albeit structureless, 
absorption spectrum. Obviously, the copper ion is 
not the only species responsible for this since the 
copper-depleted enzyme still shows absorbance 
above 300 nm. Derivatization with PH led to a 
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Fig. 1. Absorption spectra of dopamine /3-hydroxylase 
(1.6 mg/ml in 0.1 M sodium phosphate, pH 7.0) before (-) 
and after (---) derivatization with PH; and of the copper- 
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pronounced spectral change, inducing a maximum 
at 350 nm. The product having this spectrum was 
not released on acidification to pH 2.0, but it re- 
quired prolonged incubation with pronase before 
adsorption took place to the Seppak cartridge 
(prior dissolution of the disulphide bonds ap- 
peared unnecessary). Comparison of the 
chromatographic and spectral properties of the ad- 
duct and the model compound (fig.2) showed that 
the adduct is the C(S) hydrazone of PQQ and PH. 
This was confirmed by conversion experiments in 
Me$O, showing that the product had a retention 
time and absorption spectrum identical to that of 
PQQ. Quantitative determinations of the PQQ 
formed indicated that the cofactor adduct was ob- 
tained in 85% yield (assuming that the transforma- 
tion into PQQ occurred quantitatively and that 
DBH contains 1 PQQ per enzyme subunit). This is 
comparable to the finding of Fitzpatrick and 
Villafranca 1131 who observed binding of 0.94 14C- 
labeled PH per subunit. 
Wavelength [nml 
Fig.2. Chromatograms (left) and absorption spectra (right) of: a, adduct isolated from enzyme treated with PH for 16 h at 40°C; b, 
C(5) hydrazone of PQQ and PH. HPLC and photodiode array detection were performed as described in the text. Spectra were taken 
at the top of the peaks. 
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Although the enzyme became immediately in- 
hibited after PH addition, derivatization of the 
cofactor to the hydrazone required long incuba- 
tion. The hydrazone formation proceeded under 
atmospheric conditions and even under (semi) 
anaerobic conditions, this in contrast to copper- 
quinoprotein amine oxidases where azo adduct is 
formed at the very first moment and hydrazone ad- 
duct formation requires high 02 concentrations. 
The presence of electron donor (ascorbate or ferro- 
cyanide) prevented hydrazone formation in the en- 
zyme but not in the model system. Derivatization 
of copper-depleted enzyme led to the hydrazone. 
4. DISCUSSION 
Derivatization of DBH with PH led to product 
formation, as is evident from the change in the ab- 
sorption spectrum (fig.1). The product is the C(5) 
hydrazone of PQQ and PH and not the modified 
amino acid assumed by Fitzpatrick and Villafranca 
[ 131. Therefore, the proposed mechanism for PH 
inhibition [2,13] should be reconsidered. Since 
product release required incubation with pronase, 
the hydrazone is most probably bound to the pro- 
tein via a peptide bond, as in the case of copper- 
quinoprotein amine oxidases ([3-61; Van der 
Meer, R.A., unpublished). Inhibition of DBH with 
PH has been reported by several other groups so 
that it is highly unlikely that the PQQ in this en- 
zyme preparation was fortuitously bound. 
Although a role as allosteric modulator cannot be 
excluded at the moment, most probably PQQ 
functions as a cofactor in DBH, in accordance 
with the following observations: the inhibition of 
enzyme with PH and the nearly stoichiometric 
amounts (with respect to subunits) of hydrazone 
formed; the prevention of derivatization by the 
presence of electron donor; the unimpaired inhibi- 
tion and derivatization with PH of copper- 
depleted enzyme. 
The mechanism of action of DBH has been the 
subject of intensive research by a number of 
groups [1,10,13-151. As a result of these efforts, 
considerable progress has been made in understan- 
ding the kinetic features of the enzyme-catalyzed 
reaction. In particular, compelling evidence has 
been presented for the participation of a substrate- 
derived benzylic radical intermediate. However, 
the nature of dioxygen activation by enzyme- 
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bound copper is still unclear. In this respect, the re- 
quirement of two copper atoms per subunit of ful- 
ly active enzyme has not been convincingly 
accommodated in any of the catalytic schemes 
presented so far. The present finding of PQQ as an 
integral part of DBH does not seem to relieve this 
ambiguity. This may also form an explanation for 
the fact that the presence of PQQ has been 
overlooked in the past. 
On the basis of current knowledge it is not feasi- 
ble to ascribe an unequivocal role to PQQ in the 
catalytic cycle of DBH. However, from the fact 
that PQQ derivatization by PH leads to irreversi- 
ble inactivation of the enzyme, the conclusion may 
be drawn that PQQ is (at least partly) exposed in 
the active site. Although the enzyme shows a rather 
broad substrate specificity, the requirement for 
N-i 
Scheme 1. Binding of inhibitor and substrate in the active site. 
A possible binding mode of PH to PQQ, leading in a slow 
reaction to the hydrazone adduct, is depicted in A. An 
analogous arrangement is proposed for the substrate (B). The 
present data give no information on the possible participation 
of Cu(II) in the anchoring of substrate or inhibitor in the active 
site. 
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substrates containing a phenyl group seems ab- 
solute. Provided that this requirement is innate to 
a hydrophobic pocket in which either substrates or 
PH will be held in similar positions, it appears like- 
1Y that the physiological, catecholamine, 
substrate(s) are oriented with the amino group in 
close proximity to the PQQ ortho-quinone moiety. 
Recalling the (in vitro) tendency of PQQ to form 
adducts with suitable nucleophiles at the S-position 
[16], a redox-silent role for PQQ as a mere ‘an- 
choring’ point should be considered. A schematic 
topology for the active site with respect o this view 
is given in scheme 1. 
However, the observation made by us and others 
that reduced enzyme does not incorporate PH, 
may well indicate that PQQ is redox-linked to the 
copper centers. Coupling of a copper center with 
an organic redox center on the enzyme has at one 
time been proposed to account for the properties 
of DBH, then thought to contain only one copper 
per enzyme subunit [ 151. We feel that the discovery 
of PQQ in DBH warrants a reconsideration of this 
proposal. A possible cycle is depicted in scheme 2. 
As a third possibility, present knowledge might 
be adequately represented by invoking two copper 
atoms spaced and redox-connected by a PQQ 
molecule. Experiments in which PQQH2 and 
Cu(I1) were mixed anaerobically showed the rapid 
oxidation of PQQH2 to PQQ, indicating that an 
enzyme form with a Cu(I)/PQQ cluster might exist 
(Jongejan, J.A., unpublished). Such a situation 
might well account for the observed (in- 
distinguishable) redox properties of the two copper 
atoms in each subunit, thus obviating the concep- 
tual need for a closely spaced binuclear copper site. 
Discrimination between the three mechanisms is 
not clearly possible at the moment and we are well 
aware of the fact that the proposed mechanisms 
are not mutually exclusive. DBH is the first 
copper-quinoprotein hydroxylase found so far, il- 
lustrating the versatility of PQQ, It is therefore a 
matter of course to apply the ‘hydrazine method’ 
to other enzymes for which the presence of PQQ is 
suspected. 
Ascorbate Semldehydro- Ascorbate Semldehydro- 
.2-r O2 substrate 
Scheme 2. The catalytic cycle of dopamine P-hydroxylase. In 
the mechanism proposed, enzyme is reduced by ascorbate in 
two steps (a generally accepted reduction mechanism for this 
enzyme) via bound Cu(II), leading to an enzyme form 
containing Cu(1) and PQQH’. This form reacts with 02 and 
substrate. as indicated. 
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